# Agios Pharmaceuticals, Inc.: Form 8-K, filed Jul 8, 2025

- Company: [Agios Pharmaceuticals, Inc.](/companies/agio.md) (CIK 1439222)
- Form: 8-K
- Filed: 2025-07-08
- Accepted by EDGAR: Jul 8, 2025, 07:01 ET
- Period: 2025-07-03
- Accession: 0001439222-25-000076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439222/000143922225000076/agio-20250703.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439222/000143922225000076/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439222/000143922225000076/agio-20250703.htm

Filed Jul 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001439222-25-000076. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
